Gilead Sciences puts last-stage blood cancer trials on hold after FDA order
HQ Team February 8, 2024: Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US.
Drugs
Health
Pharma
Drugs
Health
Pharma
Novartis to buy MorphoSys for $2.9 billion to expand cancer portfolio
HQ Team February 6, 2024: Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss.
Drugs
Health
Pharma
Eli Lilly’s drug gets second FDA nod for treating blood cancer in adults
HQ Team December 4, 2023: Eli Lilly and Company got a second accelerated approval from the Food and Drug Administration for its blood.
Drugs
Health
Pharma
US scientists zero in on single blood cancer therapy in animal studies
HQ Team September 28, 2023: US scientists have honed in on a single chimeric antigen receptor T-cell (CAR T) therapy to cure all.
Drugs
Health
Pharma
EMA recommends stopping sale of GSK’s blood cancer drug in EU
The European Medicines Agency has recommended the stoppage of conditional marketing authorisation for GSK’s Blenrep (belantamab mafodotin), a medicine used to treat cancer of.
Drugs
Health
Pharma
US regulator approves Pfizer’s Elrexfio to treat multiple myeloma
HQ Team August 15, 2023: The USFDA has granted accelerated approval for Pfizer Inc’s Elrexfio to treat incurable blood cancer, multiple myeloma, that.
Drugs
Medical
Pharma
Eli Lilly gets FDA nod for blood cancer drug
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.